Clinical Trials Logo
  1. Home
  2. Diabetic Neuropathy, Painful
  3. NCT00385671

An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain

Diabetic Neuropathy, Painful Clinical Trial

Official title:
An Open-Label, Randomized Comparison of Duloxetine, Pregabalin, and the Combination of Duloxetine and Gabapentin Among Patients With Inadequate Response to Gabapentin for the Management of Diabetic Peripheral Neuropathic Pain

Clinical Trial Summary

To test the non-inferiority of duloxetine monotherapy as a treatment for the management of diabetic peripheral neuropathic pain as compared to pregabalin treatment among patients who have not had an adequate response to gabapentin.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00385671
Study type Interventional
Source Eli Lilly and Company
Contact
Status Completed
Phase Phase 4
Start date September 2006
Completion date November 2009
View Details
See also
  Status Clinical Trial Phase
Completed NCT04988321 - Theta Burst Brain Stimulation in Diabetic Neuropathy Patients With Neuropathic Pain: Investigating Neural Mechanisms N/A
Completed NCT00159679 - Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy Phase 4
Completed NCT00141401 - Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy. Phase 3
Active, not recruiting NCT04469270 - Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy Phase 3
Completed NCT00553475 - Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy Phase 3
Completed NCT00381719 - Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral Neuropathy Phase 2
Completed NCT00539175 - Treatment of Painful Diabetic Neuropathy With Photon Stimulation N/A
Completed NCT00058968 - A Study for the Treatment of Painful Diabetic Neuropathy Phase 3
Completed NCT05029297 - Study With Two Capsaicin Topic Treatments in Diabetic Neuropathy. Phase 3
Completed NCT02215252 - A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN) Phase 2
Completed NCT00785577 - A Study for Treatment of Pain in Patients With Diabetic Neuropathy. Phase 2
Completed NCT00858351 - Thermal Biofeedback for the Treatment of Diabetic Neuropathy N/A
Completed NCT03047278 - Transporters for Organic Cations and Glycemic Control in Patients With Neuropathic Pain. Phase 4
Completed NCT01628627 - Frequency Modulated Neural Stimulation (FREMS) in Symptomatic Diabetic Neuropathy Phase 4
Completed NCT03315598 - Evaluation of an Effectiveness and Safety of the Electroacupuncture in the Management of Intractable Neuropathic Pain N/A
Completed NCT01057693 - Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy Phase 3
Completed NCT01564459 - Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021) Phase 2
Recruiting NCT01214590 - Preliminary Assessment of the Efficacy of the VascuActive™ Device on Diabetic Peripheral Neuropathy N/A
Completed NCT01089556 - A Study in Painful Diabetic Neuropathy Phase 3
Completed NCT00501202 - Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN). Phase 2